Schroder Investment Management Group
OPRX icon

Schroder Investment Management Group’s OptimizeRx OPRX Stock Holding History

Schroder Investment Management Group’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,470
Closed -$339K – 1544
2021
Q2 		$339K Buy
+5,470
New +$278K ﹤0.01% 1268

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Schroder Investment Management Group's OPRX Position: Q3 2021 in Review

Schroder Investment Management Group sold out of OptimizeRx (OPRX) in Q3 2021, closing a stake of 5,470 shares — an estimated $339K sold.

Schroder Investment Management Group first reported a position in OPRX in Q2 2021 and held it in 1 quarter. The position peaked at $339K in Q2 2021. 163 funds tracked by Wall St. Rank hold OPRX as of Q3 2021.

  • Schroder Investment Management Group reported no remaining OptimizeRx position as of Q3 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 5,470 OptimizeRx shares in Q3 2021, an estimated $339K.
  • Schroder Investment Management Group first reported a position in OptimizeRx in Q2 2021 and held it in 1 quarter.
  • Schroder Investment Management Group's OptimizeRx position peaked at $339K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2021.

Based on Schroder Investment Management Group's 13F filing for Q3 2021, filed 12 Nov 2021.